ArticleFrontiers in drug safety and regulation2026

Comprehensive pharmacovigilance assessment of pairwise drug-drug interactions and acute pancreatitis in the FDA adverse event reporting system: focus on incretin-based drugs.

Issei Kazume et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.